Abeona Therapeutics to Engage Investors in Key Conferences

Author: Caleb Price Updated: 08-29-2025 07:47 AM

Abeona Therapeutics Investor Conference Participation

Abeona Therapeutics Inc. (Nasdaq: ABEO) recently announced an exciting lineup for investor engagement in September. As a leading biopharmaceutical company specializing in advanced therapies, Abeona is eager to share its progress and future ambitions with investors.

Upcoming Conferences

The management team at Abeona will participate in two major investor conferences:

Cantor Global Healthcare Conference 2025

On September 4, Abeona will host a fireside chat at 10:20 a.m. ET, along with scheduled investor meetings. This conference offers a platform for in-depth discussions about the company’s innovative approaches and future prospects.

H.C. Wainwright 27th Annual Global Investment Conference

Following the Cantor event, Abeona will present at the H.C. Wainwright conference on September 9 at 2:00 p.m. ET. This presentation will further highlight Abeona's cutting-edge therapies and their potential market impact.

Webcast Availability

Investors who wish to follow these developments can access a live webcast of the presentations on Abeona's investor relations website. This will include not only the live sessions but also replays for a limited period, ensuring that interested parties can catch up on what they missed.

About Abeona Therapeutics

Abeona Therapeutics stands at the forefront of biopharmaceutical advances, dedicated to developing cell and gene therapies aimed at addressing significant and serious diseases. Notably, their product ZEVASKYN™ (prademagene zamikeracel) represents a breakthrough as the first autologous cell-based gene therapy approved for treating recessive dystrophic epidermolysis bullosa (RDEB), a severe genetic skin condition.

The company operates a state-of-the-art cGMP manufacturing facility in Cleveland, Ohio, which is integral in the production of ZEVASKYN and ensures high-quality standards are maintained throughout its processes.

Innovative Development Portfolio

Abeona is also expanding its developmental horizon with a variety of gene therapies aimed at ophthalmic diseases where there remains a high unmet medical need. Their pioneering work on next-generation adeno-associated virus (AAV) capsids aims to revolutionize treatments for debilitating conditions, utilizing their innovative techniques to deliver effective therapies to those who need them most.

For further information, follow Abeona's journey and explore their offerings at www.abeonatherapeutics.com.

Frequently Asked Questions

What is the focus of Abeona Therapeutics?

Abeona Therapeutics focuses on developing cell and gene therapies for serious diseases, particularly rare genetic conditions.

What are the upcoming investor conferences Abeona will attend?

Abeona will participate in the Cantor Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference in September.

What is ZEVASKYN™?

ZEVASKYN™ is an autologous cell-based gene therapy for treating recessive dystrophic epidermolysis bullosa (RDEB).

Where is Abeona's manufacturing facility located?

The company's cGMP manufacturing facility is located in Cleveland, Ohio.

How can investors access the live presentations?

Investors can access live presentations and replays on the Investors section of the Abeona website under "Events".

About The Author

Hey there I'm Caleb Price, a writer and financial specialist who loves to assist others in understanding the financial world. Having years of practical experience and a solid background in finance, my area of expertise is converting difficult financial ideas into useful, doable insights for my blog and publications. My goal with my writing is to give readers the information and assurance they need to successfully negotiate their financial journeys.

My ability to interact with a wide range of people—from novices starting their investing journey to seasoned investors looking for new approaches—has come from contributing to several financial blogs. Making money approachable and understandable is my goal; this will enable you to make wise choices and realize your financial objectives. We appreciate you coming along on this path to success and financial empowerment on Investors Hangout.

Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.